ResearcherSouthern University of Science and TechnologyActive in the last 2 years
Peiwu Huang
Matched on ORCID iD 0000-0002-3763-1143; OpenAlex author ID A5110016557. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 4
- Clinical functional proteomics of intercellular signalling in pancreatic cancer. Co-author DOI 10.1038/s41586-024-08225-y↗
- Functional and Clinical Proteomic Exploration of Pancreatic Cancer. Co-author DOI 10.1016/j.mcpro.2023.100575↗
- Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Co-author DOI 10.1038/s41586-021-04176-w↗
- Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Co-author DOI 10.1038/s41586-019-1130-6↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ruijun Tian · 4 shared papers, 2019–2025 · strength 0.61
- Paper Functional and Clinical Proteomic Exploration of Pancreatic Cancer. DOI 10.1016/j.mcpro.2023.100575↗
- Paper Clinical functional proteomics of intercellular signalling in pancreatic cancer. DOI 10.1038/s41586-024-08225-y↗
- Paper Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. DOI 10.1038/s41586-021-04176-w↗
- Yu Shi · 3 shared papers, 2019–2025 · strength 0.34
- Paper Clinical functional proteomics of intercellular signalling in pancreatic cancer. DOI 10.1038/s41586-024-08225-y↗
- Paper Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. DOI 10.1038/s41586-021-04176-w↗
- Paper Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. DOI 10.1038/s41586-019-1130-6↗
- Tony R. Hunter · 3 shared papers, 2019–2025 · strength 0.34
- Paper Clinical functional proteomics of intercellular signalling in pancreatic cancer. DOI 10.1038/s41586-024-08225-y↗
- Paper Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. DOI 10.1038/s41586-021-04176-w↗
- Paper Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. DOI 10.1038/s41586-019-1130-6↗
- Yehan Zhang · 1 shared paper, 2025 · strength 0.20
- Yunguang Li · 1 shared paper, 2025 · strength 0.20
- Min Wang · 1 shared paper, 2025 · strength 0.20
- Dong Gao · 1 shared paper, 2025 · strength 0.20
- Renyi Qin · 1 shared paper, 2025 · strength 0.20
- Timothy R. Donahue · 2 shared papers, 2019–2021 · strength 0.14
- Kathleen E. DelGiorno · 2 shared papers, 2019–2021 · strength 0.14
- Gaoyang Liang · 2 shared papers, 2019–2021 · strength 0.14
- Nikki K. Lytle · 2 shared papers, 2019–2021 · strength 0.14
- Geoffrey Myles Wahl · 2 shared papers, 2019–2021 · strength 0.14
- Maya Ridinger-Saison · 2 shared papers, 2019–2021 · strength 0.14
- Ruilian Xu · 2 shared papers, 2019–2021 · strength 0.14
- Corina E. Antal · 2 shared papers, 2019–2021 · strength 0.14
- Carlos Roberto Becerra · 2 shared papers, 2019–2021 · strength 0.14
- Eric Andrew Collisson · 2 shared papers, 2019–2021 · strength 0.14
- Michael Anthony Hollingsworth · 2 shared papers, 2019–2021 · strength 0.14
- Paul M. Grandgenett · 2 shared papers, 2019–2021 · strength 0.14
- Andrew M. Lowy · 2 shared papers, 2019–2021 · strength 0.14
- Erkut Hasan Borazanci · 2 shared papers, 2019–2021 · strength 0.14
- Tannishtha Reya · 2 shared papers, 2019–2021 · strength 0.14
- Ronald M. Evans · 2 shared papers, 2019–2021 · strength 0.14
- Daniel D. Von Hoff · 2 shared papers, 2019–2021 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.